Zobrazeno 1 - 10
of 225
pro vyhledávání: '"N. A. Maksimov"'
Autor:
N. V. Maksimov
Publikováno v:
Scientific and Technical Information Processing. 49:238-254
Autor:
N. M. Maksimov, R. V. Toms, M. S. Balashov, A. Yu. Gerval’d, N. I. Prokopov, A. V. Plutalova, M. S. Kuzin, I. Yu. Skvortsov, V. G. Kulichikhin, E. V. Chernikova
Publikováno v:
Polymer Science, Series B. 64:670-687
Publikováno v:
Automatic Documentation and Mathematical Linguistics. 56:163-178
Autor:
I. S. Grishin, N. I. Maksimov
Publikováno v:
Clinical Medicine (Russian Journal). 100:209-213
The frequency of myocardial infarction with non-obstructive coronary arteries (MINOCA) ranges from 5 to 11.1% in the structure of all myocardial infarctions. Left ventricular myocardial performance index (LV MPI) is the only echocardiographic indepen
Autor:
N. V. Maksimov, O. L. Golitsyna
Publikováno v:
Automatic Documentation and Mathematical Linguistics. 56:145-159
Autor:
I. S. Grishin, N. I. Maksimov
Publikováno v:
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 12:117-124
Myocardial infarction without coronary artery obstruction, according to Russian authors, occurs from 4.1 to 10.3% of cases of all myocardial infarctions. Despite a fairly complete description of the term "acute myocardial infarction", there are often
Autor:
I. R. Gaisin, L. V. Rychkova, A. S. Gazimzyanova, N. I. Maksimov, S. A. Pomosov, G. M. Zaisanova, N. B. Nikolaeva, E. G. Shirobokova
Publikováno v:
PULMONOLOGIYA. 32:53-61
PH (pulmonary hypertension) targeted therapy may play an essential role in chronic thromboembolic pulmonary hypertension (CTEPH) patients considered inoperable. Given the limited number of PH-targeted drugs approved for CTEPH, reliable long-term data
Autor:
I. V. Kaplieva, V. R. Zakharchenko, E. M. Frantsiyants, N. K. Guskova, E. V. Verenikina, N. A. Maksimova, S. N. Dimitriadi, M. M. Sergeeva, M. G. Ilchenko, J. A. Pogorelova, L. K. Trepitaki
Publikováno v:
Сибирский научный медицинский журнал, Vol 44, Iss 4, Pp 105-112 (2024)
Uterine cancer (UC) is the third most common cancer in women in Russia. Knowledge of age-specific features of the fibrinolytic system in patients with UC can be useful in terms of improving its pathogenetic therapy. Aim of the study was to investigat
Externí odkaz:
https://doaj.org/article/fef628c8e34f496c986f9abc516a5b5e
Autor:
S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 1, Iss 1, Pp 4-8 (2015)
Aim. To prove the advantage of the long-term controlled antihypertensive therapy compared with the real usual standard therapy in patients with mild to moderate arterial hypertension.Material and methods. It was multicenter, randomized, prospective p
Externí odkaz:
https://doaj.org/article/55265d2cc8bf4faaad32c3b1dd31725d
Autor:
Alexey P. Puzyr, E. V. Inzhevatkin, N. K. Golubenko, A. V. Baron, N. G. Maksimov, M. V. Loshkareva, N. O. Ronzhin, Vladimir S. Bondar, M. B. Volkova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 172:77-80
Biodistribution of nanodiamonds in mice after intravenous administration, activities of AST and ALT, and the level of bilirubin in the blood plasma were studied in 2.5 h and 10, 35, and 97 days after injection of nanodiamonds. In 2.5 h after intraven